Status:
COMPLETED
Pancreas Volume in Preclinical Type 1 Diabetes
Lead Sponsor:
University of Florida
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Diabetes Action Research and Education Foundation
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
8-45 years
Brief Summary
Type 1 diabetes (T1D) is characterized by a progressive destruction of insulin producing beta cells, resulting in a lifelong dependence on exogenous insulin. While beta cells make up less than 1% of t...
Detailed Description
Participants will have blood tests and two imaging tests. The blood tests will tell us how well the pancreas is working. The imaging tests will measure the volume of the pancreas. There is one study v...
Eligibility Criteria
Inclusion
- T1D must be diagnosed less than one year
- Antibody status is know because of participation in TrialNet
- Healthy Control has no history or family history of T1D or other autoimmune disease
Exclusion
- T1D diagnosis more than one year
- Antibody satus is not know
- Healthy Control has a family history of autoimmune disease
- unable to tolerate MRI and ultrasound
Key Trial Info
Start Date :
November 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 4 2023
Estimated Enrollment :
246 Patients enrolled
Trial Details
Trial ID
NCT02234947
Start Date
November 1 2013
End Date
April 4 2023
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32610